Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670

Inclusion Criteria: * Healthy female subjects * Sterilized by tubal ligation * Age 18-45 years * Body mass index (BMI) at screening: ≥ 18 and ≤ 32 kg/m² * At least 3 consecutive regular menstrual cycles with a cycle length of 24 - 35 days before first screening examination according to the subject's history * Absence of clinically relevant abnormal findings in the pre-treatment endometrial biopsy Exclusion Criteria: * Regular use of medicines (incl. anabolics) * Incompletely cured pre-existing diseases for which it can be assumed that the absorption, distribution, metabolism, elimination and effects of the study drugs will not be normal * Amenorrhea for more than 3 months within the last 6 months before the first screening examination * Lacking suitability for frequent transvaginal ultrasonography (TVU) examinations * Clinically relevant findings (e.g. blood pressure, electrocardiogram \[ECG\], physical and gynecological examination, laboratory examination)